Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Swiss Exchange  >  Lonza Group    LONN   CH0013841017

LONZA GROUP

(LONN)
  Report  
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Swiss Exchange
07/15/2019 07/16/2019 07/17/2019 07/18/2019 07/19/2019 Date
331.1(c) 337(c) 336.4(c) 335.1(c) 339(c) Last
287 237 433 856 323 873 211 478 302 195 Volume
+1.25% +1.78% -0.18% -0.39% +1.16% Change
More quotes
Financials (CHF)
Sales 2019 5 909 M
EBIT 2019 1 215 M
Net income 2019 780 M
Debt 2019 3 100 M
Yield 2019 0,84%
Sales 2020 6 314 M
EBIT 2020 1 352 M
Net income 2020 910 M
Debt 2020 2 663 M
Yield 2020 0,95%
P/E ratio 2019 32,6x
P/E ratio 2020 28,0x
EV / Sales2019 4,78x
EV / Sales2020 4,41x
Capitalization 25 169 M
More Financials
Company
Lonza Group is one of the world leaders of the development, production and marketing of chemical products. Net sales break down by family of products and services as follows: - fine organic and performance chemical products (54.9%): for food products, hygiene products, beauty products, water... 
More about the company
Surperformance© ratings of Lonza Group
Trading Rating : Investor Rating :
More Ratings
Latest news on LONZA GROUP
07/11LONZA : Showcases Innovative Solutions to Make More Possible at the 14th Interna..
AQ
07/02LONZA : to Acquire Sterile Fill and Finish Facility from Novartis
AQ
07/01LONZA : Announces Short, Routine Shutdown of Niacinamide Plant in Nansha for Mai..
AQ
07/01Lonza fills portfolio hole by buying Novartis drug bottling plant
RE
06/26LONZA : Launches the First in a Series of Educational Videos on 'Keeping Our Wor..
AQ
06/20Lonza Publishes Restated Financials for 2018
TE
06/19LONZA : Invites Visitors to Make More Possible at Hi-Fi Asia-China 2019 with Sci..
AQ
06/11LONZA : Engine Equipment Portfolio Launched for Small Molecule Formulation and D..
AQ
06/06LONZA : to Host New Webinar Titled 'Know Your Enemy Mycoplasma Contamination in ..
AQ
06/03Carve-out of Lonza Specialty Ingredients will help segment to become a global..
TE
More news
Analyst Recommendations on LONZA GROUP
More recommendations
Sector news : Biotechnology & Medical Research - NEC
07/19Gilead Licenses Respiratory, Herpes Antiviral Research Programs From Novartis
DJ
07/17GILEAD SCIENCES : Chief Scientific Officer John McHutchison to Leave
DJ
07/16As steep patent cliff looms, Shionogi moves to develop its own U.S. sales sta..
RE
07/16GSK's two-drug HIV Dovato treatment meets main goal in study
RE
07/15Gilead invests $5 billion to deepen ties with biotech Galapagos
RE
More sector news : Biotechnology & Medical Research - NEC
Chart LONZA GROUP
Duration : Period :
Lonza Group Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends LONZA GROUP
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 15
Average target price 336,25  CHF
Last Close Price 339,00  CHF
Spread / Highest target 18,7%
Spread / Average Target -0,81%
Spread / Lowest Target -38,1%
EPS Revisions
Managers
NameTitle
Richard Ridinger Chief Executive Officer
Albert M. Baehny Chairman
Rodolfo Savitzky Chief Financial Officer
Patrick Aebischer Vice Chairman
Margot A. Scheltema Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
LONZA GROUP31.57%25 623
IQVIA HOLDINGS INC34.16%30 740
CELLTRION, INC.--.--%20 071
INCYTE CORPORATION26.66%17 271
EXACT SCIENCES CORPORATION85.26%14 835
SEATTLE GENETICS, INC.32.49%12 140